Literature DB >> 16125684

17beta-estradiol potentiates ischemia-reperfusion injury in diabetic ovariectomized female rats.

You Yong1, Hong-Ju Xie, Yue-Feng Zhang, Qi-Dong Yang, Duan-Fang Liao, Hui-Ling Yang, Peng-Ke Yan, Zun-Jing Liu.   

Abstract

UNLABELLED: To investigate the effect of 17beta-estradiol (E2) on ischemia-reperfusion (I/R) injury in diabetic ovariectomized female rats. Streptozotocin(STZ)-induced diabetic female rats received E2 treatment for 2 weeks after ovariectomy (OVX). A period of 90 min of temporary middle cerebral artery occlusion (tMCAO) was used for the study. Rats were evaluated for physiological data including plasma glucose, E2, MAP, PaCO2 and PaO2 before and after tMCAO. P-selectin expression, myeloperoxidase (MPO) enzyme activity and the cerebral infarct volume were analyzed.
RESULTS: The infarct volume in the E2-treated OVX rats is bigger than that in intact and OVX groups. However, there is not a significant different area of cerebral infarct between diabetic OVX and intact rats. Significant upregulation of P-selectin expression and MPO activity of the ischemia-reperfusion hemisphere were observed in E2 + OVX, intact and OVX groups at 8, 24, 72 h in time manner after tMCAO compared with that of the contralateral hemisphere of cerebral ischemia-reperfusion. Both P-selectin expression and MPO activity in the E2 + OVX and intact rats are significantly higher than that in the untreated OVX rats. Chronic estrogen replacement therapy (ERT) potentiates the I/R injury in diabetes female rats. This may be related to the increased expression of P-selectin and MPO activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125684     DOI: 10.1016/j.brainres.2005.05.069

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

Review 1.  Estrogen neuroprotection and the critical period hypothesis.

Authors:  Erin Scott; Quan-guang Zhang; Ruimin Wang; Ratna Vadlamudi; Darrell Brann
Journal:  Front Neuroendocrinol       Date:  2011-11-04       Impact factor: 8.606

2.  Ovariectomy and 17β-estradiol replacement in rats and mice: a visual demonstration.

Authors:  Jakob O Ström; Annette Theodorsson; Edvin Ingberg; Ida-Maria Isaksson; Elvar Theodorsson
Journal:  J Vis Exp       Date:  2012-06-07       Impact factor: 1.355

Review 3.  Mechanisms of estrogens' dose-dependent neuroprotective and neurodamaging effects in experimental models of cerebral ischemia.

Authors:  Jakob O Strom; Annette Theodorsson; Elvar Theodorsson
Journal:  Int J Mol Sci       Date:  2011-02-25       Impact factor: 5.923

4.  Different methods for administering 17beta-estradiol to ovariectomized rats result in opposite effects on ischemic brain damage.

Authors:  Jakob O Strom; Elvar Theodorsson; Lovisa Holm; Annette Theodorsson
Journal:  BMC Neurosci       Date:  2010-03-17       Impact factor: 3.288

Review 5.  Gender and the injured brain.

Authors:  Kamila Vagnerova; Ines P Koerner; Patricia D Hurn
Journal:  Anesth Analg       Date:  2008-07       Impact factor: 5.108

6.  Impact of methodology on estrogens' effects on cerebral ischemia in rats: an updated meta-analysis.

Authors:  Jakob O Ström; Edvin Ingberg
Journal:  BMC Neurosci       Date:  2014-02-04       Impact factor: 3.288

7.  Effect of gender differences on the regulation of renal ischemia-reperfusion-induced inflammation in mice.

Authors:  Kyung Pyo Kang; Jung Eun Lee; Ae Sin Lee; Yu Jin Jung; Dal Kim; Sik Lee; Hong Pil Hwang; Won Kim; Sung Kwang Park
Journal:  Mol Med Rep       Date:  2014-03-28       Impact factor: 2.952

Review 8.  Hormesis and Female Sex Hormones.

Authors:  Jakob O Strom; Annette Theodorsson; Elvar Theodorsson
Journal:  Pharmaceuticals (Basel)       Date:  2011-05-16

9.  TLR4-mediated brain inflammation halts neurogenesis: impact of hormonal replacement therapy.

Authors:  Abdeslam Mouihate
Journal:  Front Cell Neurosci       Date:  2014-05-27       Impact factor: 5.505

10.  Beneficial effects of estrogen in a mouse model of cerebrovascular insufficiency.

Authors:  Naohito Kitamura; Runa Araya; Moeko Kudoh; Haruo Kishida; Tetsuya Kimura; Miyuki Murayama; Akihiko Takashima; Yuriko Sakamaki; Tsutomu Hashikawa; Shingo Ito; Sumio Ohtsuki; Tetsuya Terasaki; Jürgen Wess; Masahisa Yamada
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.